Priti Jhingran

3.4k total citations · 1 hit paper
30 papers, 2.7k citations indexed

About

Priti Jhingran is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Priti Jhingran has authored 30 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Priti Jhingran's work include Asthma and respiratory diseases (9 papers), Gastrointestinal motility and disorders (6 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Priti Jhingran is often cited by papers focused on Asthma and respiratory diseases (9 papers), Gastrointestinal motility and disorders (6 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Priti Jhingran collaborates with scholars based in United States, United Kingdom and Netherlands. Priti Jhingran's co-authors include Mark Kosinski, Michael Schatz, Christine A. Sorkness, Trudy Pendergraft, James T. Li, Robert A. Nathan, Philip Marcus, John Murray, Michael Schätz and Maria Watson and has published in prestigious journals such as Gastroenterology, Journal of Allergy and Clinical Immunology and The American Journal of Gastroenterology.

In The Last Decade

Priti Jhingran

28 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists

2006 933 citations Michael Schatz, Christine A. Sorkness et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Priti Jhingran United States	19	1.6k	1.1k	529	333	286	30	2.7k
S. Bolge United States	22	437 0.3×	239 0.2×	217 0.4×	91 0.3×	551 1.9×	68	2.3k
Ilaria Baiardini Italy	32	2.0k 1.3×	988 0.9×	138 0.3×	618 1.9×	27 0.1×	140	3.9k
E. F. Juniper Canada	18	2.2k 1.4×	1.7k 1.5×	93 0.2×	45 0.1×	33 0.1×	32	3.3k
Somali M. Burgess United States	10	679 0.4×	497 0.4×	386 0.7×	25 0.1×	28 0.1×	14	1.7k
Chris M Kozma United States	24	288 0.2×	160 0.1×	880 1.7×	83 0.2×	32 0.1×	98	2.0k
Manan Shah United States	20	298 0.2×	575 0.5×	186 0.4×	50 0.2×	30 0.1×	78	1.7k
Károly Kulich Sweden	21	464 0.3×	735 0.7×	110 0.2×	49 0.1×	380 1.3×	43	2.0k
Trudy Pendergraft United States	8	2.8k 1.8×	2.2k 2.0×	53 0.1×	36 0.1×	37 0.1×	14	3.3k
Feride Frech United States	13	251 0.2×	88 0.1×	264 0.5×	53 0.2×	548 1.9×	41	2.0k
P Weiner Israel	33	947 0.6×	1.8k 1.6×	74 0.1×	53 0.2×	16 0.1×	92	2.7k

Countries citing papers authored by Priti Jhingran

Since Specialization

Citations

This map shows the geographic impact of Priti Jhingran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priti Jhingran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priti Jhingran more than expected).

Fields of papers citing papers by Priti Jhingran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priti Jhingran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priti Jhingran. The network helps show where Priti Jhingran may publish in the future.

Co-authorship network of co-authors of Priti Jhingran

This figure shows the co-authorship network connecting the top 25 collaborators of Priti Jhingran. A scholar is included among the top collaborators of Priti Jhingran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priti Jhingran. Priti Jhingran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loftus, Jane, Bradley S. Miller, Craig S. Parzynski, et al.. (2025). A study looking at how missed somatropin injections affect growth in children with growth hormone deficiency: a plain language summary of publication. Therapeutic Advances in Endocrinology and Metabolism. 16. 2455677726–2455677726.

Miller, Bradley S., Jane Loftus, Craig S. Parzynski, et al.. (2024). Impact of Daily Growth Hormone Adherence on Height Velocity Among Children With Growth Hormone Deficiency (GHD). Endocrine Practice. 30(9). 837–846.

Bharmal, Murtuza, et al.. (2024). Real-world evidence in the reassessment of oncology therapies: payer perceptions from five countries. Future Oncology. 20(21). 1467–1478. 2 indexed citations

Loftus, Jane, Bradley S. Miller, Craig S. Parzynski, et al.. (2022). Association of Daily Growth Hormone Injection Adherence and Height Among Children With Growth Hormone Deficiency. Endocrine Practice. 28(6). 565–571. 21 indexed citations

Loftus, Jane, et al.. (2022). Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in the UK. Frontiers in Endocrinology. 13. 1014743–1014743. 4 indexed citations

Garris, Cindy, Priti Jhingran, Damon Bass, et al.. (2013). Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan. Journal of Medical Economics. 16(5). 667–677. 85 indexed citations

Drenkard, Cristina, Gaobin Bao, Greg Dennis, et al.. (2013). Burden of Systemic Lupus Erythematosus on Employment and Work Productivity: Data From a Large Cohort in the Southeastern United States. Arthritis Care & Research. 66(6). 878–887. 76 indexed citations

Hanania, Nicola A., David M. Mannino, Barbara P. Yawn, et al.. (2010). Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respiratory Medicine. 104(8). 1160–1170. 65 indexed citations

Guilbert, Theresa W., Cindy Garris, Priti Jhingran, et al.. (2010). Asthma That Is Not Well-Controlled Is Associated with Increased Healthcare Utilization and Decreased Quality of Life. Journal of Asthma. 48(2). 126–132. 111 indexed citations

10.

Schätz, Michael, Mark Kosinski, Aaron Yarlas, et al.. (2009). The minimally important difference of the Asthma Control Test. Journal of Allergy and Clinical Immunology. 124(4). 719–723.e1. 389 indexed citations

11.

Earnshaw, Stephanie, Michele Wilson, Anand A. Dalal, et al.. (2008). Cost-effectiveness of fluticasone propionate/salmeterol (500/50μg) in the treatment of COPD. Respiratory Medicine. 103(1). 12–21. 29 indexed citations

12.

Schatz, Michael, Christine A. Sorkness, James T. Li, et al.. (2006). Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists. Journal of Allergy and Clinical Immunology. 117(3). 549–556. 933 indexed citations breakdown →

13.

O’Connor, Richard D., Amanda Gilmore, Ranjani Manjunath, et al.. (2006). Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives. Current Medical Research and Opinion. 22(3). 453–461. 12 indexed citations

14.

Gordon, Susan, et al.. (2003). Validation of Irritable Bowel Syndrome Global Improvement Scale: An Integrated Symptom End Point for Assessing Treatment Efficacy. Digestive Diseases and Sciences. 48(7). 1317–1323. 74 indexed citations

15.

Olden, Kevin W., et al.. (2002). Patient Satisfaction With Alosetron for the Treatment of Women With Diarrhea-Predominant Irritable Bowel Syndrome. The American Journal of Gastroenterology. 97(12). 3139–3146. 36 indexed citations

16.

Shih, Ya‐Chen Tina, Victoria Barghout, Robert S. Sandler, et al.. (2002). Resource Utilization Associated with Irritable Bowel Syndrome in the United States: 1987–1997. Digestive Diseases and Sciences. 47(8). 1705–1715. 30 indexed citations

17.

Lembo, Tony, et al.. (2001). Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome. The American Journal of Gastroenterology. 96(9). 2662–2670. 156 indexed citations

18.

Martin, Bradley C., et al.. (2000). Validity and Reliability of the Migraine‐Specific Quality of Life Questionnaire (MSQ Version 2.1). Headache The Journal of Head and Face Pain. 40(3). 204–216. 213 indexed citations

19.

Jhingran, Priti, et al.. (1998). Development and Validation of the Migraine‐Specific Quality of Life Questionnaire. Headache The Journal of Head and Face Pain. 38(4). 295–302. 201 indexed citations

20.

Jhingran, Priti, Sonia M. Davis, Lisa M. LaVange, David W. Miller, & Ronald W. Helms. (1998). MSQ: Migraine-Specific Quality-of-Life Questionnaire. PharmacoEconomics. 13(6). 707–717. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact